Literature DB >> 25199471

Medical marijuana for digestive disorders: high time to prescribe?

Mark E Gerich1, Robert W Isfort1, Bryan Brimhall2, Corey A Siegel3.   

Abstract

The use of recreational and medical marijuana is increasingly accepted by the general public in the United States. Along with growing interest in marijuana use has come an understanding of marijuana's effects on normal physiology and disease, primarily through elucidation of the human endocannabinoid system. Scientific inquiry into this system has indicated potential roles for marijuana in the modulation of gastrointestinal symptoms and disease. Some patients with gastrointestinal disorders already turn to marijuana for symptomatic relief, often without a clear understanding of the risks and benefits of marijuana for their condition. Unfortunately, that lack of understanding is shared by health-care providers. Marijuana's federal legal status as a Schedule I controlled substance has limited clinical investigation of its effects. There are also potential legal ramifications for physicians who provide recommendations for marijuana for their patients. Despite these constraints, as an increasing number of patients consider marijuana as a potential therapy for their digestive disorders, health-care providers will be asked to discuss the issues surrounding medical marijuana with their patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199471     DOI: 10.1038/ajg.2014.245

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  70 in total

1.  Dosing medical marijuana: rational guidelines on trial in Washington State.

Authors:  Sunil K Aggarwal; Muraco Kyashna-Tocha; Gregory T Carter
Journal:  MedGenMed       Date:  2007-09-11

Review 2.  Pharmacology and effects of cannabis: a brief review.

Authors:  C H Ashton
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

3.  Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.

Authors:  Karen Wright; Nicholas Rooney; Mark Feeney; Jeremy Tate; Duncan Robertson; Melanie Welham; Stephen Ward
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

4.  Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.

Authors:  Florian Strasser; Diana Luftner; Kurt Possinger; Gernot Ernst; Thomas Ruhstaller; Winfried Meissner; You-Dschun Ko; Martin Schnelle; Marcus Reif; Thomas Cerny
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

5.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 6.  Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.

Authors:  F C Machado Rocha; S C Stéfano; R De Cássia Haiek; L M Q Rosa Oliveira; D X Da Silveira
Journal:  Eur J Cancer Care (Engl)       Date:  2008-07-09       Impact factor: 2.520

7.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

Authors:  J E Beal; R Olson; L Laubenstein; J O Morales; P Bellman; B Yangco; L Lefkowitz; T F Plasse; K V Shepard
Journal:  J Pain Symptom Manage       Date:  1995-02       Impact factor: 3.612

8.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

9.  Marijuana use patterns among patients with inflammatory bowel disease.

Authors:  Jessica Ravikoff Allegretti; Andrew Courtwright; Matthew Lucci; Joshua R Korzenik; Jonathan Levine
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

10.  Phytochemical and genetic analyses of ancient cannabis from Central Asia.

Authors:  Ethan B Russo; Hong-En Jiang; Xiao Li; Alan Sutton; Andrea Carboni; Francesca del Bianco; Giuseppe Mandolino; David J Potter; You-Xing Zhao; Subir Bera; Yong-Bing Zhang; En-Guo Lü; David K Ferguson; Francis Hueber; Liang-Cheng Zhao; Chang-Jiang Liu; Yu-Fei Wang; Cheng-Sen Li
Journal:  J Exp Bot       Date:  2008       Impact factor: 6.992

View more
  23 in total

1.  Cannabinoid receptor agonist namisol does not affect cytokine levels in chronic pancreatitis patients.

Authors:  Wesley K Utomo; Marjan de Vries; Dagmar C van Rijckevorsel; Maikel P Peppelenbosch; Harry van Goor; Gwenny M Fuhler
Journal:  Am J Gastroenterol       Date:  2015-08       Impact factor: 10.864

2.  Response to Utomo et al.

Authors:  Robert W Isfort; Colm B Collins; Mark E Gerich
Journal:  Am J Gastroenterol       Date:  2015-08       Impact factor: 10.864

Review 3.  Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

Authors:  Kristina L Leinwand; Mark E Gerich; Edward J Hoffenberg; Colm B Collins
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

4.  miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Vinay Kumar; Joshua Mansfield; Rong Fan; Andrew MacLean; Jian Li; Mahesh Mohan
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

5.  Severity and outcomes of acute alcoholic pancreatitis in cannabis users.

Authors:  Hemant Goyal; Kelsey Guerreso; Betsy Smith; Kaitlin Harper; Sheetal Patel; Akash Patel; Puja Parikh
Journal:  Transl Gastroenterol Hepatol       Date:  2017-07-21

6.  Is There an Effect of Cannabis Consumption on Acute Pancreatitis?

Authors:  C Roberto Simons-Linares; Jodie A Barkin; Yuchen Wang; Palashkumar Jaiswal; William Trick; Michael J Bartel; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2018-06-20       Impact factor: 3.199

7.  Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.

Authors:  Kenta Kuramoto; Nan Wang; Yuying Fan; Weiran Zhang; Frank J Schoenen; Kevin J Frankowski; Juan Marugan; Yifa Zhou; Sui Huang; Congcong He
Journal:  Autophagy       Date:  2016-06-15       Impact factor: 16.016

8.  Is the Hype of Medical Marijuana All Smoke and Mirrors?

Authors:  Jenna Koliani-Pace; Corey A Siegel
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

9.  Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.

Authors:  Edward J Hoffenberg; Heike Newman; Colm Collins; Sally Tarbell; Kristina Leinwand
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

10.  Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients.

Authors:  John Gubatan; Kyle Staller; Kenneth Barshop; Braden Kuo
Journal:  Dig Dis Sci       Date:  2016-03-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.